Drug intelligence / Profile preview

ProBarimin QT

Development stage: Unknown
Administration: Oral

Overview

**ProBarimin QT** is a branded, orally disintegrating multivitamin and mineral supplement formulated for patients after bariatric surgery, providing a comprehensive blend of vitamins and trace elements in a quick-dissolving, sugar‑free tablet that can be taken without water to accommodate altered gastrointestinal anatomy and swallowing difficulties.[1][3] It is used to help prevent or correct nutritional deficiencies common after procedures such as gastric bypass or sleeve gastrectomy, with rapid dissolution on the tongue designed to enhance patient adherence and absorption in this population.[1][3]

Brand names: ProBarimin QT
Other names: ProBarimin QT Orally Disintegrating Tablet

Beyond the preview

Go deeper on ProBarimin QT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProBarimin QT.

Explore the full profile